IXHL

Incannex Healthcare (IXHL)

Incannex Healthcare Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IXHL

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/12/12	06 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/12/09	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/12/07	06 : 23	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/11/27	06 : 06	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/11/15	06 : 05	GlobeNewswire Inc.	Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/11/12	20 : 07	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/11/12	20 : 04	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/11/07	06 : 19	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/11/07	06 : 06	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/11/01	05 : 10	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/10/25	05 : 49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/10/25	05 : 48	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/10/24	20 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/10/24	20 : 30	GlobeNewswire Inc.	Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/10/24	20 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/10/22	05 : 35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/10/16	04 : 54	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/10/01	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/10/01	05 : 01	GlobeNewswire Inc.	Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/09/30	20 : 30	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/09/10	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/09/10	21 : 00	GlobeNewswire Inc.	Incannex Healthcare Announces Strategic Financing for up to $60 Million with Arena Investors	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/09/10	20 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/09/10	20 : 00	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/08/05	20 : 30	GlobeNewswire Inc.	FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/07/30	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/07/30	20 : 30	GlobeNewswire Inc.	Dosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42X	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/05/30	21 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/05/30	20 : 30	GlobeNewswire Inc.	Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/05/07	20 : 30	GlobeNewswire Inc.	Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder	NASDAQ:IXHL	Incannex Healthcare Ltd